TELA Bio, Inc. Quarterly Operating Income (Loss) in USD from Q3 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
TELA Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2018 to Q3 2024.
  • TELA Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$9.37M, a 8.02% increase year-over-year.
  • TELA Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$38M, a 7.75% increase year-over-year.
  • TELA Bio, Inc. annual Operating Income (Loss) for 2023 was -$44.1M, a 13% decline from 2022.
  • TELA Bio, Inc. annual Operating Income (Loss) for 2022 was -$39M, a 32.4% decline from 2021.
  • TELA Bio, Inc. annual Operating Income (Loss) for 2021 was -$29.5M, a 16.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$38M -$9.37M +$816K +8.02% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$38.9M -$11.6M -$1.21M -11.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$37.6M -$4.83M +$6.43M +57.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$44.1M -$12.3M -$2.84M -30.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 -$41.2M -$10.2M -$694K -7.32% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$40.5M -$10.4M -$125K -1.22% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$40.4M -$11.3M -$1.41M -14.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$39M -$9.44M -$1.79M -23.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 -$37.2M -$9.49M -$2.27M -31.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$35M -$10.2M -$2.93M -40% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$32M -$9.84M -$2.58M -35.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$29.5M -$7.65M -$907K -13.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-22
Q3 2021 -$28.5M -$7.22M -$354K -5.16% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$28.2M -$7.31M -$2.15M -41.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$26M -$7.27M -$770K -11.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$25.3M -$6.75M -$921K -15.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 -$24.4M -$6.86M -$3.01M -78% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$21.3M -$5.17M -$866K -20.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$20.5M -$6.5M -$1.32M -25.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$19.2M -$5.83M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-23
Q3 2019 -$3.86M -$1.33M -52.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$4.3M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$5.18M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q3 2018 -$2.52M Jul 1, 2018 Sep 30, 2018 10-Q 2019-12-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.